GLS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 bal. 2023 @ 23:00):

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases...

Stats
Dzisiejszy wolumen	185 167
Średni wolumen	570 667
Kapitalizacja rynkowa	11.63M
EPS	$0 ( 2024-03-26 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.122
ATR14	$0.0180 (148.76%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-20	Puretech Health Plc	Buy	0	Convertible Note
2023-06-12	Puretech Health Plc	Buy	0	Convertible Note
2023-05-26	Puretech Health Plc	Buy	43 133 803	Warrants
2023-05-26	Puretech Health Plc	Buy	0	Convertible Note
2023-05-01	Puretech Health Plc	Buy	192 307 692	Warrants

INSIDER POWER
99.97
Last 86 transactions
Buy: 269 373 579 \| Sell: 26 728 050

Wolumen Korelacja

Długi: -0.10 (neutral)

Krótki: -0.99 (very strong negative)

Signal:(31.483) Neutral

Gelesis Holdings, Inc. Korelacja

10 Najbardziej pozytywne korelacje
TBI	0.855
VFC	0.849
NBHC	0.848
AFG	0.839
AUD	0.836
HP	0.832
COP	0.827
ETRN	0.825
DVN	0.822
BOC	0.821

10 Najbardziej negatywne korelacje
DSE	-0.846
IOT	-0.83
BBL	-0.812
IDT	-0.811
MIC	-0.811
FPAC-UN	-0.805
YEXT	-0.805

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Gelesis Holdings, Inc. Korelacja - Waluta/Towar

-0.85
( strong negative )

-0.84
( strong negative )

0.00
( neutral )

-0.93
( very strong negative )

-0.11
( neutral )

0.66
( moderate )

Gelesis Holdings, Inc. Finanse

Annual	2022
Przychody:	$25.77M
Zysk brutto:	$-1.79M (-6.95 %)
EPS:	$-0.790

FY	2022
Przychody:	$25.77M
Zysk brutto:	$-1.79M (-6.95 %)
EPS:	$-0.790

FY	2021
Przychody:	$11.19M
Zysk brutto:	$1.20M (10.75 %)
EPS:	$-0.0423

Financial Reports:

No articles found.

Gelesis Holdings, Inc.

Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.